Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, December 2014

Sort by: Newest first Oldest first A-Z Z-A

  • White adipose tissue

    Researchers pinpoint new approach to treating obesity Subscription

    22 DEC 2014 16:02
    Comments (1)

    Researchers have identified group 2 innate lymphoid cells for the first time in human white adipose tissue and shown that it limits obesity.

  • nsaids skin biopsy solar elastosis actinic keratosis 14

    NSAIDs may help protect against skin cancer Subscription

    22 DEC 2014 15:49 By Joanna Lyford

    The use of non-steroidal anti-inflammatory drugs (NSAIDs), a class of medicines used to treat pain and inflammation, is associated with a reduced risk of developing cutaneous squamous cell carcinoma (SCC), a type of skin cancer, research suggests.

  • Oxygen therapy for COPD patient

    Oxygen therapy reduces dyspnoea in COPD patients with mild disease Subscription

    22 DEC 2014 11:35

    Continuous oxygen during exertion, but not short-burst therapy, significantly reduces dyspnoea in patients with mild chronic obstructive pulmonary disease, researchers find.

  • Depo-Provera stock issues Subscription

    19 DEC 2014 15:27

    Stock of Depo-Provera (medroxyprogesterone acetate; Pfizer) 150mg/ml will be exhausted by 25 December 2014. The company anticipates that supply will resume in the week commencing 12 January 2015. Medical information on 01304 616161. Further information on 0845 6088866.   

  • The Brain and SSRIs

    Researchers examine why SSRIs take time to work Subscription

    19 DEC 2014 15:25

    Researchers have shown that serotonergic neurons release both serotonin and glutamate, thereby transmitting a dual signal with behaviourally distinct effects.

  • Merton Sandler, a pioneer in psychopharmacology and authority on monoamines

    Merton Sandler (1926-2014) Subscription

    19 DEC 2014 12:05 By Joanna Lyall

    Merton Sandler was fascinated by investigative medicine and was a passionate researcher, who would often use himself as a test subject.

  • Steps to secure a summer placement in a community pharmacy

    How you can secure a summer placement in community pharmacy

    19 DEC 2014 9:16 By Ailsa Colquhoun

    Applications for those all-important community pharmacy summer placements are open now. Here’s how you can secure your place.

  • Novartis Christmas opening hours Subscription

    18 DEC 2014 10:49

    The main switchboard at Novartis will be closed from 1pm on 24 December 2014 until the morning of 2 January 2015. Medical information will be available on 01276 698370 until 1pm on 24 December and from 10am until 4pm on 29–31 December. An emergency medical information service will be available outside these hours, also on 01276 698370. Customer care (for orders) will be available on 0845 7419442 between 8.30am and 2.30pm on 24 December, between 9am and ...

  • Gardasil side effects Subscription

    18 DEC 2014 10:40

    The summary of product characteristics of Gardasil (human papillomavirus vaccine; Sanofi Pasteur) now includes acute disseminated encephalomyelitis as an adverse event with frequency not known. 

  • NICE recommends ustekinumab for psoriatic arthritis Subscription

    18 DEC 2014 10:39

    The National Institute for Health and Care Excellence (NICE) has issued draft guidance for consultation recommending that use of ustekinumab (Stelara; Janseen-Cilag) on the NHS for the treatment of psoriatic arthritis in specific circumstances. NICE rejected the drug in May 2014 but, following the introduction of a patient access scheme, has proposed a reversal of this decision. ...

  • SMC December 2014 decisions Subscription

    18 DEC 2014 10:31

    In the latest round of decisions by the Scottish Medicines Consortium(SMC), a number of medicines have been accepted for use in NHS Scotland; obinutuzumab (Gazyvaro; Roche), pemetrexed (Alimta; Eli Lilly), pomalidomide (Imnovid; Celegene), umeclidinium (Incruse; GlaxoSmithKline), cholecalciferol 25,000 international units oral solution ...

  • Rezolsta available for HIV Subscription

    17 DEC 2014 17:02

    Rezolsta, a darunavir 800mg and cobicistat 150mg combination tablet, is now available from Janssen for the treatment of HIV in adults. NHS list price, 30 tablets, £317.24. 

  • E-cigarettes and tobacco control in Scotland Subscription

    17 DEC 2014 17:00

    The Scottish Government is consulting on proposals to limit young people’s access to e-cigarettes and to curb smoking in cars with young people. Full details of the proposals can be found on the Scottish government’s website. Comments can be submitted until 2 January 2015. 

  • Managing diabetes NPA resource Subscription

    17 DEC 2014 17:00

    The National Pharmacy Association (NPA) has produced a diabetes resource pack for community pharmacy. ‘Managing diabetes in community pharmacy’ will be distributed to members of the NPA in December 2014. 

  • Risk of hyperglycaemia for diabetes patients using faulty insulin pens Subscription

    17 DEC 2014 16:45

    People with diabetes using insulin pens from a number of faulty batches manufactured by Owen Mumford are at risk of hyperglycaemia.

  • Sick day rules for reducing patients’ risk of acute kidney injury (AKI)

    Initiative seeks to protect patients from acute kidney injury

    16 DEC 2014 15:08 By Gareth Malson

    If you have not yet heard of sick day rules for reducing patients’ risk of acute kidney injury (AKI), you probably will soon.

  • Sue Sharpe, the chief executive of the Pharmaceutical Services Negotiating Committee, said that when NHS England launched its consultation, it said the sector could expect a further document on the proposed features of its strategic framework for commissi

    Leaders undeterred by missing commissioning plan for pharmacy Subscription

    15 DEC 2014 16:39 By Ingrid Torjesen
    Comments (1)

    Pharmacy bodies remain hopeful that pharmacy will play a meaningful role in new models of NHS care, despite the lack of a formal response to the Call to Action consultation.

  • Use of antiretroviral therapy could contribute to a reduction in HIV virulence at the population level, study finds

    Use of antiretroviral therapy will drive down HIV virulence Subscription

    15 DEC 2014 16:35
    Comments (1)

    HIV is evolving relatively rapidly, which is contributing to a reduction in HIV virulence at the population level, say researchers writing in PNAS.

  • Clinical trials of the VSV-ZEBOV Ebola vaccine have been halted because some participants developed joint pain after receiving the injection, says a press release issued by the University Hospitals of Geneva

    Ebola clinical trial suspended after volunteers complain of joint pains Subscription

    12 DEC 2014 16:49 By Joanna Lyford

    A phase I clinical trial of the fast-tracked Ebola vaccine VSV-ZEBOV has been halted in Switzerland because some trial participants developed mild joint pain.

  • Duaklir Genuair now available Subscription

    12 DEC 2014 11:30

    Duaklir Genuair (aclidinium bromide and formoterol fumarate) dry powder inhaler 340μg/12μg is now available from AstraZeneca for use as a maintenance brochodilator to relieve symptoms of chronic obstructive pulmonary disease in adults. Net price: 1 x 60-dose inhaler, £32.50.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.